English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduResults from this large-scale synthesis of all prior clinical trials could increase usage of several types of high-resolution imaging for guiding interventional coronary procedures
Tag: Cardiovascular Research
Mount Sinai Renames Top-Ranked Heart Hospital to Honor Valentin Fuster, MD, PhD, and His Legacy of Excellence
“Mount Sinai Fuster Heart Hospital” furthers vision of world-leading cardiac care and research that prevents heart disease worldwide
Mount Sinai Announces Partnership With the Chiba Institute of Technology in Japan Focusing on Artificial Intelligence to Transform Cardiovascular Research
Agreement aims to help make clinical trials more efficient and lead to faster advances in patient care
George Dangas, MD, PhD, Named President of Society for Cardiovascular Angiography & Interventions
First Mount Sinai cardiologist to hold this prestigious position
Researchers Show That a Machine Learning Model Can Improve Mortality Risk Prediction for Cardiac Surgery Patients
A machine learning-based model that enables medical institutions to predict the mortality risk for individual cardiac surgery patients has been developed by a Mount Sinai research team, providing a significant performance advantage over current population-derived models.
A Novel Mechanism May Be Effective in Patients With Severe Hypertriglyceridemia and Prior Episodes of Acute Pancreatitis
A novel type of therapy, known as ANGPTL3 inhibitor therapy, was effective in lowering triglycerides in certain types of patients with severe hypertriglyceridemia (sHTG) who had a prior episode(s) of acute pancreatitis. sHTG is a well-established risk factor for recurrent episodes of acute pancreatitis. These high-risk patients were the focus of a phase 2 study that was led by the Icahn School of Medicine at Mount Sinai and sponsored and funded by Regeneron.
Valentin Fuster, MD, PhD, Receives Prestigious Award from City of Barcelona, Spain
Mount Sinai Heart President given top honor for his extraordinary scientific achievements
Deepak L. Bhatt, MD, MPH, Named Director of Mount Sinai Heart
Will also serve as the first-ever Dr. Valentin Fuster Professor of Cardiovascular Medicine
Valentin Fuster, MD, PhD, Named President of Mount Sinai Heart
Mount Sinai Health System’s globally acclaimed cardiologist Valentin Fuster, MD, PhD, has been named President of Mount Sinai Heart, a newly created position, effective Sunday, January 1, 2023. Dr. Fuster will continue in his roles as Physician-in-Chief of The Mount Sinai Hospital and as the Richard Gorlin, MD/Heart Research Foundation Professor at the Icahn School of Medicine at Mount Sinai.
“Polypill” Reduces Cardiovascular Mortality by 33 Percent in Patients Treated After a Heart Attack
A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.
Blacks Found Twice as Likely to Have Atherosclerosis as Hispanics in Young Adult Populations in Underserved Communities
A unique Mount Sinai study focused on a multi-ethnic, underserved community in New York City shows that young Black adults are twice as likely to have atherosclerosis as similarly situated young Hispanic adults.
Specific Environmental Exposures may Help Predict Increased Risk of Death from Cardiovascular Disease
A new study from the Icahn School of Medicine at Mount Sinai quantifies the cardiovascular risk posed by exposure to specific environmental factors, showing, for example, that air pollution heightens the risk of heart disease mortality by 17 percent.
American Heart Association Honors Two Penn Medicine Scientists for Achievements in Research
Two Penn Medicine faculty members, Kiran Musunuru, MD, PhD, and Daniel Rader, MD, are being honored with prestigious awards from the American Heart Association (AHA) for their achievements in cardiovascular research. Both awards will be presented during the Presidential Session on Sunday, Nov. 14, at the association’s Scientific Sessions 2021.
Mount Sinai Recruits Internationally Recognized Cardiovascular Immunology Researcher
Filip Swirski, PhD, named Director of Mount Sinai’s new Cardiovascular Research Institute
New research could lead to treatment for aortic aneurysms
Thanks to a $5.6 million grant from the NIH, a University of Kentucky College of Medicine team will study the culprit behind thoracic aortic aneurysms, which could lead to a treatment for the potentially deadly disease.
Mount Sinai Cardiovascular Doctors to Receive Honors During American College of Cardiology 70th Annual Scientific Session
William Whang, MD, Associate Professor of Medicine (Cardiology), and Gilbert Tang, MD, MSc, MBA, Associate Professor of Cardiovascular Surgery at the Icahn School of Medicine at Mount Sinai, are receiving the 2021 Simon Dack Awards for their exceptional contributions to the Journal of the American College of Cardiology (JACC).
Study Shows Significant Reduction in Triglycerides in Patients at High Risk for Acute Pancreatitis Through Novel Monoclonal Antibody
The investigational drug evinacumab reduced triglycerides in patients with severe hypertriglyceridemia (sHTG) and a history of hospitalizations for acute pancreatitis in a phase 2 global study led by Mount Sinai
Mount Sinai’s Valentin Fuster, MD, PhD, Honored by Thai Royal Family for Outstanding Medical Contributions
Thailand’s Royal Family has named Valentin Fuster, MD, PhD, Director of Mount Sinai Heart and Physician-in-Chief of The Mount Sinai Hospital, a winner of the 29th annual Prince Mahidol Award in the field of Medicine.